Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Lemaitre Vascular (LMAT)

$23.52 0.00 (0.00%)

16:46 EDT LMAT Stock Quote Delayed 20 Minutes

Volume:

Previous Close $23.52

Market Cap 454.23M

PE Ratio 26.43

EPS 0.89

Volume (Avg. Vol.)

Day's Range 23.52 - 23.52

52-Week Range 18.76 - 38.64

Dividend & Yield 0.27 (1.13%)

LMAT Stock Predictions, Articles, and Lemaitre Vascular News

From InvestorPlace
From the Web

5 Healthcare Stocks That Are Down, But Not Out!

By Josh Enomoto, InvestorPlace Contributor Aug 29, 2018

Tough headwinds have impacted several healthcare stocks, presenting opportunities for risk-tolerant speculators.

5 MedTech Stocks to Pick for Stellar Returns

By Zacks Investment Research Sep 22, 2017

While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.

The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test

From Benzinga Mar 24, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

Have Insiders Been Selling LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares This Year?

From Simply Wall St Mar 20, 2020

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular/news/have-insiders-been-selling-lemaitre-vascular-inc-nasdaqlmat-shares-this-year-2/">Read More...</a></div>

Lemaitre Vascular (LMAT) was Upgraded to a Buy Rating at Sidoti

From Analyst Ratings Mar 16, 2020

Sidoti analyst James Sidoti upgraded Lemaitre Vascular (LMAT – Research Report) to Buy today and set a price target of $38.00. The company’s shares closed last Monday at $24.45. According to TipRanks.com, Sidoti is ranked #4462 out of 6185 analysts. Currently, the analyst consensus on Lemaitre Vascular is a Moderate Buy with an average price

Does LeMaitre Vascular, Inc.’s (NASDAQ:LMAT) CEO Pay Reflect Performance?

From Simply Wall St Mar 9, 2020

In 1992 George LeMaitre was appointed CEO of LeMaitre Vascular, Inc. (NASDAQ:LMAT). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we’ll<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular/news/does-lemaitre-vascular-inc-s-nasdaqlmat-ceo-pay-reflect-performance/">Read More...</a></div>

Why You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming Dividend

From Simply Wall St Feb 26, 2020

Readers hoping to buy LeMaitre Vascular, Inc. (NASDAQ:LMAT) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. You can purchase shares<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular/news/why-you-might-be-interested-in-lemaitre-vascular-inc-nasdaqlmat-for-its-upcoming-dividend/">Read More...</a></div>

Estimating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

From Simply Wall St Feb 25, 2020

How far off is LeMaitre Vascular, Inc. (NASDAQ:LMAT) from its intrinsic value? Using the most recent financial data, we’ll take a look at whether the stock is fairly priced by<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-lmat/lemaitre-vascular/news/estimating-the-fair-value-of-lemaitre-vascular-inc-nasdaqlmat/">Read More...</a></div>

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold